Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Gross Profit (2020 - 2025)

Roivant Sciences' Gross Profit history spans 6 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 85.17% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $13.5 million, down 62.55%, while the annual FY2025 figure was $28.1 million, 9.55% down from the prior year.
  • Gross Profit reached $1.3 million in Q4 2025 per ROIV's latest filing, down from $1.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $23.0 million in Q4 2021 to a low of $1.3 million in Q4 2025.
  • Average Gross Profit over 5 years is $8.3 million, with a median of $7.6 million recorded in 2021.
  • Peak YoY movement for Gross Profit: soared 1150.99% in 2021, then plummeted 85.17% in 2025.
  • A 5-year view of Gross Profit shows it stood at $23.0 million in 2021, then plummeted by 41.34% to $13.5 million in 2022, then rose by 14.1% to $15.4 million in 2023, then tumbled by 42.99% to $8.8 million in 2024, then tumbled by 85.17% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Gross Profit are $1.3 million (Q4 2025), $1.5 million (Q3 2025), and $2.0 million (Q2 2025).